Autism Diagnostics Lab Announces the U.S. Launch of the First Commercial Urine-Based Microbial-Derived Metabolite (MDM™) Gut & Brain Health Test for Autism Screening
Newly available test measures microbially derived metabolites associated with a distinct autism phenotype
Non-invasive screening tool designed to help identify children at risk for autism earlier and support clinical decision-making
Test is supported by peer-reviewed research published in Molecular Psychiatry, a Nature portfolio journal
PHOENIX, June 17,